What is the recommended dose and frequency of Benadryl (diphenhydramine)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Benadryl (Diphenhydramine) Dosing and Frequency

For adults and children over 12 years, the standard dose is 25-50 mg (10-20 mL) every 4-6 hours, not exceeding 6 doses in 24 hours; for children 6 to under 12 years, give 25 mg (10 mL) every 4-6 hours. 1

Standard Dosing by Age

Adults and Children ≥12 Years

  • Dose: 25-50 mg (10-20 mL) per dose 1
  • Frequency: Every 4-6 hours 1
  • Maximum: 6 doses in 24 hours 1

Children 6 to <12 Years

  • Dose: 25 mg (10 mL) per dose 1
  • Frequency: Every 4-6 hours 1
  • Maximum: 6 doses in 24 hours 1

Children <6 Years

  • Do not use without physician direction 1

Context-Specific Dosing

Acute Allergic Reactions (Outpatient/Emergency)

  • Dose: 1-2 mg/kg per dose 2
  • Maximum single dose: 50 mg 2
  • Route: IV or oral (oral liquid absorbs better than tablets) 2
  • Post-discharge: Continue every 6 hours for 2-3 days 2
  • Alternative: Consider non-sedating second-generation antihistamines when sedation is problematic 2

Acute Dystonic Reactions

  • Dose: 1-2 mg/kg 3
  • Maximum initial dose: 50 mg 3
  • Route: IV or IM 3
  • Frequency: Every 4-6 hours as needed 3
  • Critical warning: Rapid IV administration may precipitate seizures 3

Premedication (e.g., for immunosuppressive therapy)

  • Pediatric dose: 1 mg/kg 2
  • Given before agents like thymoglobulin, rituximab, or IVIg 2

Critical Dosing Considerations for Elderly Patients

Patients over 85 years require reduced doses due to heightened anticholinergic sensitivity and increased risk of delirium, cognitive impairment, and falls. 4, 3

  • Strongly consider alternative non-sedating antihistamines instead 4
  • If diphenhydramine must be used, reduce standard adult doses 4, 3
  • Monitor closely for confusion, delirium, urinary retention, and falls 4, 3

Important Clinical Pitfalls

Inappropriate Uses to Avoid

  • Do NOT use for insomnia: The American Academy of Sleep Medicine explicitly recommends against diphenhydramine for sleep disorders (only 8-minute reduction in sleep latency vs placebo, no quality improvement) 3
  • For elderly insomnia, consider doxepin 3-6 mg instead 4, 3

Toxicity Thresholds

  • Children <6 years: Refer to emergency department if ingestion ≥7.5 mg/kg 5
  • Patients ≥6 years: Refer to emergency department if ingestion ≥7.5 mg/kg OR ≥300 mg (whichever is less) 5

Adverse Effects Requiring Monitoring

  • CNS effects: Confusion, delirium (especially elderly), impaired psychomotor performance 4, 3
  • Anticholinergic effects: Dry mouth, blurred vision, urinary retention, constipation 4, 3
  • Cardiovascular effects: Hypotension, tachycardia, cardiac toxicity with rapid IV administration 3

Safer Alternatives

Second-generation antihistamines (cetirizine, fexofenadine, loratadine) provide equivalent efficacy with significantly less sedation and cognitive impairment, making them preferable for most indications. 6, 7

  • Cetirizine has the fastest onset among newer antihistamines 7
  • Fexofenadine causes no psychomotor or cognitive impairment 7
  • Cost difference is minimal ($0.52-2.39 more per dose) 7
  • Consider these alternatives particularly when sedation poses safety concerns (driving, operating machinery, elderly patients) 7

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Diphenhydramine Dosing Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Diphenhydramine Use in Elderly Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Diphenhydramine: Time to Move on?

The journal of allergy and clinical immunology. In practice, 2022

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.